Cardiovascular Disease

OCTOPUS: What Really Causes MI in Younger Patients

Young heart attack patients might actually be a completely different disease population than previously understood, after the OCTOPUS registry analysis revealed that the causes of early MI and the people who get them aren’t what’s expected.

  • Currently the accepted most common cause of heart attacks in young people is typically coronary artery disease due to plaque buildup.
  • Other accepted major factors include genetics, substance abuse, hypertension, obesity, and less commonly, spontaneous coronary artery dissection (SCAD).

The OCTOPUS registry analyzed 4k cardiac events between 2003-2018, using medical record linkage to classify MI etiologies in patients 18-65 years old, but what researchers found could challenge our usual assumptions about young MI patients…

  • Atherothrombosis caused 67% of MIs overall, but supply-demand mismatch (when the heart’s oxygen demand exceeds its oxygen supply) accounted for 23%.
  • Meanwhile, SCAD accounted for 4%, MINOCA-U for 3%, embolism for 2%, and vasospasm for 1% of young MIs.
  • Angiographic review led to MI cause reclassification in 4% of cases, most commonly changing MINOCA-U diagnoses to SCAD and atherothrombosis to coronary embolism.

Given these distinct etiological patterns, the findings suggest young MI patients require fundamentally different diagnostic and therapeutic approaches compared to older populations with predominantly atherosclerotic disease.

  • For example, takotsubo syndrome (temporary LV weakening) showed concerning long-term outcomes with 26% noncardiovascular mortality at 5 years in patients with a median age of just 54.
  • Many supply-demand mismatch patients (64%) didn’t undergo angiography, meaning there could be potential for reclassification with better evaluation.

The Takeaway

The OCTOPUS analysis reveals that young MI patients represent a much more uniform population where nonatherosclerotic causes predominate. This challenges the traditional atherosclerosis-focused approach to MI management and highlights the critical importance of accurate initial diagnosis, especially for conditions like SCAD where inappropriate intervention can cause harm.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Atrial Fibrillation November 10, 2025

ARREST-AF and the Importance of Lifestyle Post-Ablation November 10, 2025

Catheter ablation for atrial fibrillation might be missing half its potential, after results from the ARREST-AF trial demonstrated that structured lifestyle and risk factor management significantly increases a patient’s 12-month freedom from arrhythmia while cutting recurrence risk nearly in half. That could be changing now, thanks to the ARREST-AF trial which randomized 122 patients with […]

Heart Failure November 6, 2025

PREVENT-TAHA8 Supports Stem Cells for Post-MI HF November 6, 2025

Stem cell therapy for post-MI heart failure might deserve a second look, after the PREVENT-TAHA8 trial demonstrated that mesenchymal stem cell infusion within days of STEMI significantly reduced 3-year HF incidence. Based in Iran, the PREVENT-TAHA8 trial, randomized 396 patients following LAD STEMI with LVEF <40%, to receive either an intracoronary mesenchymal stem cell infusion […]

Structural Heart November 3, 2025

Abbott’s Tendyne TMVR System Works Even in the Sickest MR Patients November 3, 2025

New research presented at TCT 2025 suggests that Abbott’s FDA-approved Tendyne TMVR system leads to significantly better health outcomes in patients with severe mitral annular calcification who were previously considered untreatable. The SUMMIT-MAC trial enrolled 103 patients with severe MAC and found that the challenging patient population showed strong outcomes despite extreme pathology… However, patients […]